debate: drug of choice for exon 19 del egfr mutant nsclc - any egfr tki
Published 9 years ago • 1.4K plays • Length 13:26Download video MP4
Download video MP3
Similar videos
-
16:22
debate: drug of choice for exon 19 del egfr mutant nsclc - afatinib
-
20:35
tki-resistant egfr-mutant nsclc
-
14:30
adjuvant therapy for egfr mutant nsclc
-
20:24
targeted treatment with egfr tkis: front line options
-
10:45
debate: adjuvant egfr-directed therapy for patients with early stage nsclc? - no
-
21:35
long term management of egfr-mutant nsclc -tsao
-
5:47
egfr tkis for upfront treatment of nsclc
-
1:56
what targeted therapies are used for people with the egfr mutation?
-
17:42
oligoprogressive non-small cell lung cancer | 2024 living with egfr-mutant lung cancer patient forum
-
44:03
egfr: the challenge of primary and secondary resistance
-
14:23
treatment updates: egfr-mutant lung cancer | 2024 living with egfr-mutant lung cancer patient forum
-
10:06
debate: what is the optimal timing for egfr-targeted therapy? - favor frontline therapy
-
10:05
debate: what is the optimal timing for egfr-targeted therapy? - favor maintenance
-
23:10
egfr mutation positive tumors: treatment strategies in front line and at relapse
-
21:09
mechanisms of resistance to egfr tki and new treatment strategies
-
19:53
managing progression in egfr-mutant nsclc patients: potential impact of 2nd and 3rd generation tkis?
-
6:57
egfr exon 20 mutations in non–small cell lung cancer
-
23:02
dr ullas batra | dissecting molecular differences between egfr exon 19 & 21 l858r mutations
-
37:23
nsclc: integrating egfr-inhibiting therapies into clinical pathways for first-line treatment
-
8:37
debate: adjuvant egfr-directed therapy for patients with early stage nsclc? - yes
-
2:04
jack west, md: use of tki therapy in patients with egrf exon 19 deletion nsclc
-
1:37
david spigel, md: use of tki therapy in patients with egrf exon 19 deletion nsclc